AIRSUPRA

Albuterol/Budesonide

AIRSUPRA

SABAICS MDI

Albuterol / Budesonide · AstraZeneca

Clinical Reference

Active Medication & Mechanism

Albuterol sulfate SABA
90 mcg albuterol per actuation

Short-acting beta2-adrenergic agonist. Relaxes bronchial smooth muscle by activating beta2-receptors, increasing cAMP, and producing rapid bronchodilation within minutes.
Budesonide ICS
80 mcg per actuation

Corticosteroid with anti-inflammatory properties. Reduces airway inflammation and edema to help prevent worsening of symptoms during acute episodes.

FDA-Approved Dosing by Indication

// approval varies by strength + age

Asthma

1/1 approved regimens

Strength	Population	Dose & Frequency	Total Daily	Status
90/80 mcg	Patients ≥18 years	2 inhalations as needed for bronchoconstriction symptoms For the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in adults with asthma. Not for scheduled maintenance use.	Maximum 12 inhalations (1080/960 mcg) per 24 hours	FDA Approved

90/80 mcg FDA Approved

Pop · Patients ≥18 years

2 inhalations as needed for bronchoconstriction symptoms

For the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in adults with asthma. Not for scheduled maintenance use.

Total · Maximum 12 inhalations (1080/960 mcg) per 24 hours